Emergent BioSolutions CEO and leadership

Robert Kramer is a President & Chief Executive Officer at EMERGENT BIOSOLUTIONS INC., Board Member at EMERGENT BIOSOLUTIONS INC., and Interim Exec VP:Services at EMERGENT BIOSOLUTIONS INC. and is based in Lansing, Michigan. He has experience at PHARMACIA CORP and has worked as Pres:Biosciences Div at EMERGENT BIOSOLUTIONS INC., Consultant at EMERGENT BIOSOLUTIONS INC., and President at Emergent Biodefense Ops Lansg. Robert works or has worked as Chief Executive Officer at Emergent Biodefense Operations. He studied at WESTERN KENTUCKY UNIVERSITY between 1980 and 1983 and Clemson University between 1975 and 1979.

Katy Strei is an Exec VP:Human Resources/Chief Human Resources Ofcr at EMERGENT BIOSOLUTIONS INC. and Dir:Exec Development at FEDERAL NATIONAL MORTGAGE ASSOCIATION FANNIE MAE and is based in Gaithersburg, Maryland. She has experience at ManorCare Health Services-Tice Valley and has worked as Exec VP:HR/Chief Human Resources Ofcr at EMERGENT BIOSOLUTIONS INC., Principal at Katy Strei Consulting, and Analyst at SLM CORP. Katy attended Lawrence University between 1980 and 1984, St Lawrence University, and American University/The.

Ms. Kennedy, Senior Vice President, Chief Ethics and Compliance Officer, has been with Emergent BioSolutions since September 2016. Prior to working at Emergent, Ms. Kennedy served as Senior Vice President, Ethics and Compliance at SAIC where she designed and implemented a comprehensive Ethics and Compliance program. Prior to joining SAIC, Ms. Kennedy was the Vice President, Global Compliance and Chief Ethics Officer at Honeywell Inc. and was in private practice serving as a partner at Jenner & Block, Holland & Knight, and Seyfarth Shaw.

Ms. Kennedy is a recognized expert in Ethics and Compliance who leverages decades of legal and business expertise to implement “best in class” ethics, compliance and risk management programs. She has extensive experience in private practice, specializing in regulatory law and international trade compliance, and in serving as the Chief Ethics and Compliance Officer of global Fortune 500 companies. She is a thought leader in developing strategy, policy and comprehensive ethics and compliance programs using practical, innovative tools and integrated approaches to detect and prevent wrongdoing.

Highly accomplished business leader and operating executive with outstanding record of achievement. CFO of publicly-traded companies and Senior Finance Executive in Fortune 50 enterprise. Deep capital markets knowledge raising $46 billion in 27 deals. Significant restructuring and risk management experience. Strong capabilities in M&A, corporate finance, investor relations, financial operations and corporate real estate.Specialties: Capital raising, M&A, debt restructuring, complex transaction execution, investor relations, strategic planning, operational analysis, cost reduction

Transformational Information Technology Leader & Consultant ● IT Executive Coach ● Trusted Advisor to the CIO

Robert Kramer is a President & Chief Executive Officer at EMERGENT BIOSOLUTIONS INC., Board Member at EMERGENT BIOSOLUTIONS INC., and Interim Exec VP:Services at EMERGENT BIOSOLUTIONS INC. and is based in Lansing, Michigan. He has experience at PHARMACIA CORP and has worked as Pres:Biosciences Div at EMERGENT BIOSOLUTIONS INC., Consultant at EMERGENT BIOSOLUTIONS INC., and President at Emergent Biodefense Ops Lansg. Robert works or has worked as Chief Executive Officer at Emergent Biodefense Operations. He studied at WESTERN KENTUCKY UNIVERSITY between 1980 and 1983 and Clemson University between 1975 and 1979.